Matches in SemOpenAlex for { <https://semopenalex.org/work/W2114009223> ?p ?o ?g. }
- W2114009223 endingPage "629" @default.
- W2114009223 startingPage "621" @default.
- W2114009223 abstract "Background The aim of the study was to examine extrastriatal dopamine D2/3 receptor binding and psychopathology in schizophrenic patients, and to relate binding potential (BP) values to psychopathology. Methods Twenty-five drug-naive schizophrenic patients and 20 healthy controls were examined with single-photon emission computerized tomography (SPECT) using the D2/3-receptor ligand [123I]epidepride. Results In the hitherto largest study on extrastriatal D2/3 receptors we detected a significant correlation between frontal D2/3 BP values and positive schizophrenic symptoms in the larger group of male schizophrenic patients, higher frontal BP values in male (n = 17) compared to female (n = 8) patients, and – in accordance with this – significantly fewer positive schizophrenic symptoms in the female patients. No significant differences in BP values were observed between patients and controls; the patients, however, had significantly higher BP in the right compared to the left thalamus, whereas no significant hemispheric imbalances were observed in the healthy subjects. Conclusions The present data are the first to confirm a significant correlation between frontal D2/3 receptor BP values and positive symptoms in male schizophrenic patients. They are in agreement with the hypothesis that frontal D2/3 receptor activity is significant for positive psychotic symptoms. Additionally, the data support a thalamic hemispheric imbalance in schizophrenia. The aim of the study was to examine extrastriatal dopamine D2/3 receptor binding and psychopathology in schizophrenic patients, and to relate binding potential (BP) values to psychopathology. Twenty-five drug-naive schizophrenic patients and 20 healthy controls were examined with single-photon emission computerized tomography (SPECT) using the D2/3-receptor ligand [123I]epidepride. In the hitherto largest study on extrastriatal D2/3 receptors we detected a significant correlation between frontal D2/3 BP values and positive schizophrenic symptoms in the larger group of male schizophrenic patients, higher frontal BP values in male (n = 17) compared to female (n = 8) patients, and – in accordance with this – significantly fewer positive schizophrenic symptoms in the female patients. No significant differences in BP values were observed between patients and controls; the patients, however, had significantly higher BP in the right compared to the left thalamus, whereas no significant hemispheric imbalances were observed in the healthy subjects. The present data are the first to confirm a significant correlation between frontal D2/3 receptor BP values and positive symptoms in male schizophrenic patients. They are in agreement with the hypothesis that frontal D2/3 receptor activity is significant for positive psychotic symptoms. Additionally, the data support a thalamic hemispheric imbalance in schizophrenia." @default.
- W2114009223 created "2016-06-24" @default.
- W2114009223 creator A5015994033 @default.
- W2114009223 creator A5022227993 @default.
- W2114009223 creator A5029444100 @default.
- W2114009223 creator A5054139831 @default.
- W2114009223 creator A5055136911 @default.
- W2114009223 creator A5061654519 @default.
- W2114009223 creator A5062967626 @default.
- W2114009223 creator A5069982622 @default.
- W2114009223 creator A5081883606 @default.
- W2114009223 date "2006-09-01" @default.
- W2114009223 modified "2023-10-17" @default.
- W2114009223 title "Frontal Dopamine D2/3 Receptor Binding in Drug-Naive First-Episode Schizophrenic Patients Correlates with Positive Psychotic Symptoms and Gender" @default.
- W2114009223 cites W1500173777 @default.
- W2114009223 cites W1572703550 @default.
- W2114009223 cites W1965048827 @default.
- W2114009223 cites W1973371295 @default.
- W2114009223 cites W1977138162 @default.
- W2114009223 cites W1981625862 @default.
- W2114009223 cites W1981964004 @default.
- W2114009223 cites W1982283113 @default.
- W2114009223 cites W1982835775 @default.
- W2114009223 cites W1987615968 @default.
- W2114009223 cites W1996327177 @default.
- W2114009223 cites W1998338034 @default.
- W2114009223 cites W1999342452 @default.
- W2114009223 cites W2002132239 @default.
- W2114009223 cites W2015465857 @default.
- W2114009223 cites W2016135017 @default.
- W2114009223 cites W2021832124 @default.
- W2114009223 cites W2022961682 @default.
- W2114009223 cites W2025754741 @default.
- W2114009223 cites W2033873948 @default.
- W2114009223 cites W2044430408 @default.
- W2114009223 cites W2047295580 @default.
- W2114009223 cites W2051809205 @default.
- W2114009223 cites W2055356711 @default.
- W2114009223 cites W2056039872 @default.
- W2114009223 cites W2066322085 @default.
- W2114009223 cites W2067742161 @default.
- W2114009223 cites W2071235832 @default.
- W2114009223 cites W2073455106 @default.
- W2114009223 cites W2081029036 @default.
- W2114009223 cites W2081867925 @default.
- W2114009223 cites W2084760609 @default.
- W2114009223 cites W2084916174 @default.
- W2114009223 cites W2091188999 @default.
- W2114009223 cites W2091746982 @default.
- W2114009223 cites W2092111603 @default.
- W2114009223 cites W2092416470 @default.
- W2114009223 cites W2092820864 @default.
- W2114009223 cites W2094579484 @default.
- W2114009223 cites W2095366603 @default.
- W2114009223 cites W2095878413 @default.
- W2114009223 cites W2101948750 @default.
- W2114009223 cites W2105441345 @default.
- W2114009223 cites W2111335060 @default.
- W2114009223 cites W2112593299 @default.
- W2114009223 cites W2124374526 @default.
- W2114009223 cites W2126680030 @default.
- W2114009223 cites W2130055540 @default.
- W2114009223 cites W2140606211 @default.
- W2114009223 cites W2150760506 @default.
- W2114009223 cites W2156768950 @default.
- W2114009223 cites W2160249470 @default.
- W2114009223 cites W2162570433 @default.
- W2114009223 cites W2235622386 @default.
- W2114009223 doi "https://doi.org/10.1016/j.biopsych.2006.01.010" @default.
- W2114009223 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16580642" @default.
- W2114009223 hasPublicationYear "2006" @default.
- W2114009223 type Work @default.
- W2114009223 sameAs 2114009223 @default.
- W2114009223 citedByCount "86" @default.
- W2114009223 countsByYear W21140092232012 @default.
- W2114009223 countsByYear W21140092232013 @default.
- W2114009223 countsByYear W21140092232014 @default.
- W2114009223 countsByYear W21140092232015 @default.
- W2114009223 countsByYear W21140092232016 @default.
- W2114009223 countsByYear W21140092232017 @default.
- W2114009223 countsByYear W21140092232018 @default.
- W2114009223 countsByYear W21140092232019 @default.
- W2114009223 countsByYear W21140092232020 @default.
- W2114009223 countsByYear W21140092232021 @default.
- W2114009223 countsByYear W21140092232022 @default.
- W2114009223 countsByYear W21140092232023 @default.
- W2114009223 crossrefType "journal-article" @default.
- W2114009223 hasAuthorship W2114009223A5015994033 @default.
- W2114009223 hasAuthorship W2114009223A5022227993 @default.
- W2114009223 hasAuthorship W2114009223A5029444100 @default.
- W2114009223 hasAuthorship W2114009223A5054139831 @default.
- W2114009223 hasAuthorship W2114009223A5055136911 @default.
- W2114009223 hasAuthorship W2114009223A5061654519 @default.
- W2114009223 hasAuthorship W2114009223A5062967626 @default.
- W2114009223 hasAuthorship W2114009223A5069982622 @default.
- W2114009223 hasAuthorship W2114009223A5081883606 @default.
- W2114009223 hasConcept C118552586 @default.
- W2114009223 hasConcept C123273963 @default.